Serplulimab Combined With SOX Chemotherapy Improves Event Free Survival in Gastric Cancer
Trial shows serplulimab improves outcomes for gastric cancer patients
Neoadjuvant serplulimab plus SOX chemotherapy significantly improves event-free survival and safety profiles for PD-L1-positive gastric aden…
A new clinical trial finds that adding the drug serplulimab to chemotherapy significantly extends event-free survival for certain types of s…
Serplulimab plus chemotherapy improves overall survival compared to chemotherapy alone in nsq-NSCLC
Trial shows serplulimab improves survival in certain lung cancers
This Phase III randomized controlled trial of 636 treatment-naïve patients with locally advanced or metastatic nsq-NSCLC found that serpluli…
A new clinical trial shows that adding serplulimab to chemotherapy can extend life for patients with specific types of non-small cell lung c…
Review of immune checkpoint inhibitor-associated diabetes mellitus in two patients
Diabetes Danger Lingers Months After Cancer Treatment Ends
This narrative review and case report describes two patients with immune checkpoint inhibitor-associated diabetes mellitus. The authors synt…
• Some patients develop dangerous diabetes long after stopping immunotherapy • Helps cancer survivors using newer immune-boosting drugs • St…
Serplulimab with FOLFOX showed disease control in AFP-producing gastric adenocarcinoma with liver metastases
Rare Stomach Cancer Shrinks After New Combo Treatment
This case report and literature review describes a 67-year-old man with AFP-producing gastric adenocarcinoma and liver metastases treated wi…
A rare stomach cancer that spread to the liver shrank dramatically when doctors combined standard chemotherapy with a newer immune-boosting …
Phase II Trial Explores Serplulimab and Chemoradiotherapy for GEJ Adenocarcinoma
Can a new treatment approach improve outcomes for patients with advanced stomach cancer?
A phase II trial investigates serplulimab with mSOX and radiotherapy in 48 patients with cStage III GEJ adenocarcinoma.
A new trial combines immunotherapy, chemotherapy, and radiation to clear advanced stomach cancer before surgery, aiming for no surviving cel…